Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Characterization of a new Pseudomonas aeruginosa Queuovirinae bacteriophage

View through CrossRef
ABSTRACT The ESKAPEE pathogen Pseudomonas aeruginosa is a common cause of chronic wound and cystic fibrosis lung infections, as well as acute burn and nosocomial infections. Many of these infections are recalcitrant to conventional antibiotic therapies due to both traditional antibiotic resistance mechanisms and antimicrobial tolerance. Recent successes with bacteriophage (phage) therapy to treat chronic human P. aeruginosa infections have led to a renewed interest in isolating and characterizing new P. aeruginosa phages. Here, we isolated and characterized a new lytic phage (termed PIP, pili-infecting phage) capable of infecting P. aeruginosa PA14. PIP is a tailed phage with an icosahedral head and flexible tail containing a genome that is 57,462 bp in length. Phylogenetic analysis reveals that PIP belongs to the subfamily Queuovirinae and genus Nipunavirus but is highly divergent in gene content from known Nipunaviruses. By isolating and characterizing a P. aeruginosa strain that spontaneously evolved resistance to PIP, we show that the receptor for PIP is Type IV pili. In summary, we isolated a new P. aeruginosa phage species with a unique genome, thus increasing the diversity of phages known to infect this important human pathogen. IMPORTANCE The opportunistic pathogen Pseudomonas aeruginosa causes both acute and chronic human infections. These infections are notoriously difficult to treat due to both antibiotic resistance and antibiotic tolerance. The increasing frequency of antibiotic failure in P. aeruginosa infections has led scientists to explore other treatment options, including bacteriophage (phage) therapy. To this end, there has been a significant effort to identify new Pseudomonas phages. Here, we isolated and characterized a bacteriophage (termed PIP, pili-infecting phage) that infects P. aeruginosa PA14. Examination of the PIP genome revealed that this phage represents a new species in the subclass Queuovirinae. The isolation and characterization of spontaneous PA14 mutants that are resistant to PIP infection revealed Type IV pili as the PIP receptor. Ultimately, this study characterizes a new species of Pseudomonas phage, thus enhancing the known diversity of phages that infect this important pathogen.
Title: Characterization of a new Pseudomonas aeruginosa Queuovirinae bacteriophage
Description:
ABSTRACT The ESKAPEE pathogen Pseudomonas aeruginosa is a common cause of chronic wound and cystic fibrosis lung infections, as well as acute burn and nosocomial infections.
Many of these infections are recalcitrant to conventional antibiotic therapies due to both traditional antibiotic resistance mechanisms and antimicrobial tolerance.
Recent successes with bacteriophage (phage) therapy to treat chronic human P.
aeruginosa infections have led to a renewed interest in isolating and characterizing new P.
aeruginosa phages.
Here, we isolated and characterized a new lytic phage (termed PIP, pili-infecting phage) capable of infecting P.
aeruginosa PA14.
PIP is a tailed phage with an icosahedral head and flexible tail containing a genome that is 57,462 bp in length.
Phylogenetic analysis reveals that PIP belongs to the subfamily Queuovirinae and genus Nipunavirus but is highly divergent in gene content from known Nipunaviruses.
By isolating and characterizing a P.
aeruginosa strain that spontaneously evolved resistance to PIP, we show that the receptor for PIP is Type IV pili.
In summary, we isolated a new P.
aeruginosa phage species with a unique genome, thus increasing the diversity of phages known to infect this important human pathogen.
IMPORTANCE The opportunistic pathogen Pseudomonas aeruginosa causes both acute and chronic human infections.
These infections are notoriously difficult to treat due to both antibiotic resistance and antibiotic tolerance.
The increasing frequency of antibiotic failure in P.
aeruginosa infections has led scientists to explore other treatment options, including bacteriophage (phage) therapy.
To this end, there has been a significant effort to identify new Pseudomonas phages.
Here, we isolated and characterized a bacteriophage (termed PIP, pili-infecting phage) that infects P.
aeruginosa PA14.
Examination of the PIP genome revealed that this phage represents a new species in the subclass Queuovirinae.
The isolation and characterization of spontaneous PA14 mutants that are resistant to PIP infection revealed Type IV pili as the PIP receptor.
Ultimately, this study characterizes a new species of Pseudomonas phage, thus enhancing the known diversity of phages that infect this important pathogen.

Related Results

Prevalence and risk factors of Pseudomonas aeruginosa colonization
Prevalence and risk factors of Pseudomonas aeruginosa colonization
AbstractPseudomonas aeruginosa (P. aeruginosa) is one of the most concerning pathogens due to its multidrug resistance. P. aeruginosa can be a part of the normal commensal flora of...
A Study of Isolation and Identification of Multidrug Resistant Pseudomonas aeruginosa from Wound Specimen
A Study of Isolation and Identification of Multidrug Resistant Pseudomonas aeruginosa from Wound Specimen
Background: Pseudomonas aeruginosa is a clinically important pathogenic microbe in hospitalized patients. It is a major cause of mortality and morbidity having a number of mechanis...
Pseudomonas Species Prevalence, Protein Analysis, and Antibiotic Resistance: An Evolving Public Health Challenge
Pseudomonas Species Prevalence, Protein Analysis, and Antibiotic Resistance: An Evolving Public Health Challenge
Abstract Psychrotrophic Pseudomonas is one of the significant microbes that lead to putrefaction in chilled meat. One of the biggest problems in the detection of Pseudomona...
The Bacteriophage Efficiency and Antibiotics Susceptibility against Escherichia Coli and Staphylococcus Aureus
The Bacteriophage Efficiency and Antibiotics Susceptibility against Escherichia Coli and Staphylococcus Aureus
IntroductionThis study was held on the in vitro tests for the bacteriophages and their efficiency comparing with the antibiotics susceptibility in destroying bacteria. Because the ...
Secondary metabolites produced during Aspergillus fumigatus and Pseudomonas aeruginosa biofilm formation
Secondary metabolites produced during Aspergillus fumigatus and Pseudomonas aeruginosa biofilm formation
AbstractIn Cystic Fibrosis (CF), mucus plaques are formed in the patient’s lung, creating a hypoxic condition and a propitious environment for colonization and persistence of many ...

Back to Top